Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

Autor: Roberts KE; Department of Medical Oncology, Princess Alexandra Hospital, Woolloongabba, Australia.; School of Clinical Medicine, Mater Clinical Unit, Mater Hospital, University of Queensland, South Brisbane, Australia., Adsett IT; Ipswich Hospital, Queensland Health, Ipswich, Australia., Rickett K; The University of Queensland Library, UQ/Mater McAuley Library, Brisbane, Australia., Conroy SM; Medical Oncology, Mater Health, Brisbane, Australia., Chatfield MD; Centre for Health Services Research, The University of Queensland, Woolloongabba, Australia., Woodward NE; School of Clinical Medicine, Mater Clinical Unit, Mater Hospital, University of Queensland, South Brisbane, Australia.; Department of Medical Oncology, Mater Misericordiae Ltd, South Brisbane, Australia.

Publikováno v: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2022 Jan 10; Vol. 1. Cochrane AN: CD013167. Date of Electronic Publication: 2022 Jan 10.